Target intelligence / Profile preview

Improved circulation

Overview

"Improved circulation" refers to the enhancement of blood flow throughout the circulatory system, commonly targeted as a therapeutic endpoint in cardiovascular disease. This effect is typically achieved by modulating diverse molecular targets such as ion channels, G protein-coupled receptors, vasoactive enzymes (e.g., nitric oxide synthase, angiotensin-converting enzyme), and signaling molecules affecting vascular tone, smooth muscle cell contraction, or endothelial function[1][4][2]. However, "Improved circulation" itself is not a discrete molecule or receptor but rather the result of modulating these underlying pathways.

Beyond the preview

Go deeper on Improved circulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Improved circulation.

Explore the full profile